|
Product* |
Solids
Content*
in % |
K-Value*
|
NVP*
in % |
Comomomer*
in % |
|
LUVITEC® K 17
Powder |
≥ 95% |
15 - 19 |
100 |
|
|
LUVITEC® K 30
Powder |
≥ 95% |
27 - 33 |
100 |
|
|
LUVITEC® K 30
Solution 30% |
30 |
27 - 33 |
100 |
|
|
LUVITEC® K 60
Solution 35% |
35 |
52 - 62 |
100 |
|
|
LUVITEC® K 80
Powder |
≥ 95% |
74 - 82 |
100 |
|
|
LUVITEC® K 85
Powder |
≥ 95% |
84 - 88 |
100 |
|
|
LUVITEC® K 85 CQ
Solution 20% |
20 |
83 - 88 |
100 |
|
|
LUVITEC® K 90
Powder |
≥ 95% |
88 - 92 |
100 |
|
|
LUVITEC® K 90 HM
Powder |
≥ 95% |
92 - 96 |
100 |
|
|
LUVITEC® K 90 CQ
Solution 10% |
10 |
90 - 98 |
100 |
|
|
LUVITEC® K 90
Solution 20% |
20 |
90 - 98 |
100 |
|
|
LUVITEC® K 115 CQ
Solution 10% |
11 |
114 - 130 |
100 |
|
|
LUVICROSS®
Powder |
≥ 95% |
- |
98 |
2
(Crosslinker) |
|
LUVITEC® VA 64 P
Powder |
≥ 95% |
28 - 32 |
60 |
40
(Vinylacetate) |
|
LUVITEC® VA 64 W
Solution |
50 |
28 - 32 |
60 |
40
(Vinylacetate) |
|
COLLACRAL® VAL
Solution |
30 |
50 - 60 |
|
hydrophobic
modified
VP/VA-Copolymer |
|
LUVITEC® VPC 55 K 65 W
Solution |
30 |
62 - 68 |
50 |
50
(Vinylcaprolactam) |
